Lopid? contains gemfibrozil, a fibrate class lipid-lowering agent used primarily to reduce elevated triglyceride levels and increase HDL cholesterol. It activates peroxisome proliferator-activated receptor-alpha (PPAR-?), leading to enhanced lipid metabolism and decreased triglyceride synthesis. Lopid? is particularly beneficial in patients with hypertriglyceridemia.